Elena S Ratner MD
Gynecologic Oncology
Associate Professor, co-Division Director, Gynecologic Oncology,Yale University School of Medicine
Join to View Full Profile
800 Howard AveYale Physicians Bldg 3RD FLRNew Haven, CT 06519
Phone+1 203-785-4176
Fax+1 203-785-5886
Dr. Ratner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Elena Ratner is an obstetrician/gynecologist in New Haven, CT and is affiliated with multiple hospitals in the area, including Yale-New Haven Hospital and Lawrence + Memorial Hospital. She received her medical degree from University at Buffalo, School of Medicine and Biomedical Sciences and has been in practice 14 years. She specializes in gynecologic oncology and is experienced in general obstetrics and gynecology and gynecologic oncology.
Education & Training
Yale-New Haven Medical CenterFellowship, Gynecologic Oncology, 2007 - 2010- Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 2003 - 2007
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2003
Certifications & Licensure
CT State Medical License 2007 - 2027
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- "Showing some care": interest-holders' perspectives on addressing health-related social conditions in ovarian cancer.Anand R Habib, Sarah Pitafi, Elena Ratner, Emily Abramsohn, Stacy Tessler Lindau
The Oncologist. 2026-03-09 - Remarkable preclinical activity of trastuzumab-deruxtecan (T-DXd) in FISH-negative, HER2 IHC 1+ and 2+ expressing primary endometrial cancer cell lines and xenografts.Luca Palmieri, Stefania Bellone, Cem Demirkiran, Tobias M P Hartwich, Namrata Sethi
Gynecologic Oncology. 2026-03-01 - Addressing dermatologic toxicities in gynecologic cancer: development and evaluation of a patient education pamphlet.Lenique K L Huggins, Sabrina M Saeed, Mica C G Williams, Elena Ratner, Jonathan S Leventhal
International Journal of Women's Dermatology. 2026-03-01
Journal Articles
- Phase II Evaluation of Nivolumab in the Treatment of Persistent or Recurrent Cervical Cancer (NCT02257528/NRG-GY002)Alessandro D Santin, Michael Frumovitz, Natalia Buza, Samir Khleif, Elena S Ratner, Roisin E O'Cearbhaill, Michael Birrer, Gynecologic Oncology
Press Mentions
“We Need More Advocacy”: Tackling the Biggest Challenges in Ovarian Cancer CareJanuary 23rd, 2026- Why Some Doctors Say There Are Cancers That Shouldn’t Be TreatedDecember 8th, 2025
- Cancer Warning Signs for Women from Yale's Dr. Elena RatnerMarch 17th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
